Metabolon Expands Inflammation Portfolio with Targeted Panels for Cannabinoids, Sphingolipids, and Lipid Mediators of Inflammation
Targeted metabolomics panels provide absolute quantitation to further scientific discovery and inflammation research MORRISVILLE, N.C., Jan. 17, 2023 /PRNewswire/ —
Read More